Connect with us


This Is the Best News Yet for Moderna’s COVID Vaccine – The Motley Fool

The company avoided a much-dreaded scenario.



post featured image

Moderna(NASDAQ:MRNA) has announced its share of good news in the past couple of months. The biotech company generated positive results in the phase 3 trial of its investigational coronavirus vaccine. Then, the U.S. Food and Drug Administration granted the product Emergency Use Authorization in the weeks that followed. Moderna also has signed advance purchase agreements for 2021 that represent more than $11 billion in revenue. That’s a big deal for a company that didn’t have product revenue just…

Click here to view the original article.

Continue Reading

You might also like ...

Article feature image
One Medical gave COVID-19 vaccines to ineligible people, NPR report says – The Verge
Coronavirus Today: California variant is a homegrown triple threat – Los Angeles Times
Article feature image
Orange County’s coronavirus metrics gain ground; late vaccines arrive – OCRegister